The oral GpIIb/IIIa antagonist (XV454) inhibits tumor cell-induced platelet aggregation in vivo and suppresses experimental lung metastasis. Meeting Abstract

Industry Collaboration

cited authors

  • Amirkhosravi, A, Mousa, SA, Amaya, M, Blaydes, S, Desai, H, Meyer, T, Francis, JL

Publication Date

  • November 16, 2001

webpage

published in

category

start page

  • 243A

end page

  • 243A

volume

  • 98

issue

  • 11

WoS Citations

  • 0

WoS References

  • 0